SOUTH SAN FRANCISCO, CA, USA (Press Release) - May 28, 2009
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
Your session will expire in 8 hours requiring you to log in each day to view content.